Save 20% on Press Releases and More with NNW Prime! Click to View Details
WednesdaySep 02, 2020 4:20 pm

Profire Energy Inc. (NASDAQ: PFIE) Starts Presentation at The LD 500

Profire Energy Inc. (NASDAQ: PFIE) assists energy production companies in the safe and efficient production and transportation of oil and natural gas. As energy companies seek greater safety for their employees, compliance with more stringent regulatory standards and enhanced margins with their energy production processes, Profire Energy's burner management products are continuing to be a key part of their solutions. Profire Energy has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; Millersburg, Ohio; and Acheson, Alberta, Canada. For more information, visit the company's website at www.profireenergy.com About The LD 500 The LD 500 is the most ambitious project…

Continue Reading

WednesdaySep 02, 2020 4:00 pm

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Starts Presentation at The LD 500

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America's key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery ("ISR") Project in Wyoming and the Alta Mesa ISR Project in Texas. In addition, Energy Fuels has one of the largest NI 43-101-compliant…

Continue Reading

WednesdaySep 02, 2020 3:40 pm

Predictive Oncology Inc. (NASDAQ: POAI) Starts Presentation at The LD 500

Predictive Oncology Inc. (NASDAQ: POAI) operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology's Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and…

Continue Reading

WednesdaySep 02, 2020 3:40 pm

NeoGenomics Inc. (NASDAQ: NEO) Starts Presentation at The LD 500

NeoGenomics Inc. (NASDAQ: NEO) specializes in cancer genetics testing and information services. The company provides one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. The company's pharma services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, Florida, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego, California; Houston, Texas; Atlanta, Georgia; and Nashville, Tennessee. It also operates CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic…

Continue Reading

WednesdaySep 02, 2020 3:40 pm

Mace Security International Inc. (OTCQX: MACE) Starts Presentation at The LD 500

Mace Security International Inc. (OTCQX: MACE) is a globally recognized leader in personal safety products. The company has spent more than 30 years designing and manufacturing consumer and tactical products for personal defense and security under its world-renowned Mace(R) brand – the original trusted brand of pepper spray products. The company's other leading brands include Tornado(R) brand stun guns and pepper spray, and Vigilant(R) brand personal alarms. The company also offers aerosol defense sprays for law enforcement and security professionals worldwide through its Take Down(R) brand. Mace Security International distributes and supports its products and services through mass-market retailers, wholesale…

Continue Reading

WednesdaySep 02, 2020 3:40 pm

Advaxis Inc. (NASDAQ: ADXS) Starts Presentation at The LD 500

Advaxis Inc. (NASDAQ: ADXS) is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-based strains are believed to be a significant advancement in immunotherapy, as they integrate multiple functions into a single immunotherapy and are designed to access and direct antigen presenting cells to stimulate anti-tumor T cell immunity, activate the immune system with the equivalent of multiple adjuvants and simultaneously reduce tumor protection in the tumor microenvironment to enable…

Continue Reading

WednesdaySep 02, 2020 3:20 pm

Slinger Bag Inc. (OTC: SLBG) Starts Presentation at The LD 500

Slinger® is a new sports brand focused on delivering innovative, game improvement technologies and equipment across all Ball Sport categories. With the vision to become a next-generation sports consumer products company, Slinger® enhances the skill and enjoyment levels of players of all ages and abilities. Slinger® is initially focused on building its brand within the global Tennis market, through its Slinger® Tennis Ball Launcher and Accessories. Slinger® has underpinned its proof of concept with over $1 Million in sales of its Tennis Ball Launcher. Led by CEO Mike Ballardie (former Prince CEO and Wilson EMEA racquet sports executive), Slinger® is now primed to continue to disrupt…

Continue Reading

WednesdaySep 02, 2020 3:20 pm

Optex Systems Holdings Inc. (OTCQB: OPXS) Starts Presentation at The LD 500

Optex Systems Holdings Inc. (OTCQB: OPXS) is a Richardson, Texas-based ISO 9001:2015 certified concern, which manufactures optical sighting systems and assemblies, primarily for Department of Defense (DOD) applications. Its products are installed on various types of U.S. military land vehicles, such as the Abrams and Bradley fighting vehicles and light armored and armored security vehicles, and they have been selected for installation on the Stryker family of vehicles. Optex also manufactures and delivers numerous periscope configurations, rifle and surveillance sights and night vision optical assemblies. Optex delivers its products both directly to the military services and to prime contractors. For…

Continue Reading

WednesdaySep 02, 2020 3:20 pm

Applied Energetics Inc. (OTCQB: AERG) Starts Presentation at The LD 500

Applied Energetics Inc. (OTCQB: AERG) specializes in the development and manufacture of advanced high-performance lasers, high voltage electronics, advanced optical systems and integrated guided energy systems for defense, aerospace, industrial and scientific customers worldwide. Applied Energetics pioneered and holds all crucial intellectual property rights to the development and use of laser guided energy technology and related solutions for commercial, defense and security applications and is protected by 26 patents and 11 additional government sensitive patent applications. The company's 11 GSPA's are held under secrecy orders of the U.S. government and allow Applied Energetics greatly extended protection rights. For more information,…

Continue Reading

WednesdaySep 02, 2020 3:20 pm

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) Starts Presentation at The LD 500

Adial Pharmaceuticals Inc. (NASDAQ: ADIL) is a clinical-stage biopharmaceutical company focusing on the development of treatments for addictions. The company's lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist therapeutic agent for the treatment of alcohol use disorder (AUD). AD04 is being investigated in a landmark ONWARD(TM) pivotal Phase 3 clinical trial. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency and quantity of drinking. AD04 is also believed to have the potential to treat other addictive disorders such as opioid use disorder, gambling and obesity. For…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000